AAAAAA
Results:
1-7
|
Results: 7
Authors:
DIAVCITRIN O
PARK YH
VEERASUNTHARAM G
POLACHEK H
BOLOGA M
PASTUSZAK A
KOREN G
Citation: O. Diavcitrin et al., THE SAFETY OF MESALAMINE IN HUMAN-PREGNANCY - A PROSPECTIVE CONTROLLED COHORT STUDY, Gastroenterology, 114(1), 1998, pp. 23-28
Authors:
DIAVCITRIN O
ATANACKOVIC G
KOREN G
Citation: O. Diavcitrin et al., CORRELATION BETWEEN INITIAL HEPATIC IRON CONCENTRATION AND RESPONSE TO DEFERIPRONE (L1) IN PATIENTS WITH BETA-THALASSEMIA MAJOR, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 77-77
Authors:
LOEBSTEIN R
DIAVCITRIN O
ATANACKOVIC G
OLIVIERI NF
KOREN G
Citation: R. Loebstein et al., DEFERIPRONE-INDUCED AGRANULOCYTOSIS - A CRITICAL-REVIEW OF 5 RECHALLENGED CASES, Clinical drug investigation, 13(6), 1997, pp. 345-349
Authors:
SHER GD
DIAVCITRIN O
HALL GA
TYLER B
OLIVIERI NF
CAMERON R
FEINMAN SV
KRAJDEN M
Citation: Gd. Sher et al., PREVALENCE AND CLINICAL-SIGNIFICANCE OF HEPATITIS-G VIRUS-INFECTION IN RBC TRANSFUSION RECIPIENTS, Transfusion, 37(9), 1997, pp. 349-349
Authors:
DIAVCITRIN O
KOREN G
Citation: O. Diavcitrin et G. Koren, ORAL IRON CHELATION WITH DEFERIPRONE, The Pediatric clinics of North America, 44(1), 1997, pp. 235
Authors:
LOEBSTEIN R
ZAHID N
DIAVCITRIN O
ATANACKOVIC G
UETRECHT J
KOREN G
Citation: R. Loebstein et al., DEFERIPRONE(L1)-INDUCED AGRANULOCYTOSIS - A POSSIBLE MECHANISM, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 9-9
Authors:
DIAVCITRIN O
ATANACKOVIC G
LOEBSTEIN R
KOREN G
Citation: O. Diavcitrin et al., INVESTIGATION OF VARIABILITY IN RESPONSE TO DEFERIPRONE(L1) IN PATIENTS WITH BETA-THALASSEMIA MAJOR, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 38-38
Risultati:
1-7
|